首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Combining computational and experimental screening for rapid optimization of protein properties
【24h】

Combining computational and experimental screening for rapid optimization of protein properties

机译:结合计算和实验筛选以快速优化蛋白质特性

获取原文
获取原文并翻译 | 示例
       

摘要

We present a combined computational and experimental method for the rapid optimization of proteins. Using β-lactamase as a test case, we redesigned the active site region using our Protein Design Automation technology as a computational screen to search the entire sequence space. By eliminating sequences incompatible with the protein fold, Protein Design Automation rapidly reduced the number of sequences to a size amenable to experimental screening, resulting in a library of ≈200,000 mutants. These were then constructed and experimentally screened to select for variants with improved resistance to the antibiotic cefotaxime. In a single round, we obtained variants exhibiting a 1,280-fold increase in resistance. To our knowledge, all of the mutations were novel, i.e., they have not been identified as beneficial by random mutagenesis or DNA shuffling or seen in any of the naturally occurring TEM β-lactama-ses, the most prevalent type of Gram-negative β-lactamases. This combined approach allows for the rapid improvement of any property that can be screened experimentally and provides a powerful broadly applicable tool for protein engineering.
机译:我们提出了一种结合计算和实验方法来快速优化蛋白质的方法。使用β-内酰胺酶作为测试案例,我们使用蛋白质设计自动化技术作为计算屏幕重新设计了活性位点区域,以搜索整个序列空间。通过消除与蛋白质折叠不兼容的序列,Protein Design Automation迅速将序列数减少到适合实验筛选的大小,从而形成了一个约200,000个突变体的文库。然后构建这些并进行实验筛选,以选择对抗生素头孢噻肟具有增强抗性的变体。在单个回合中,我们获得了表现出1,280倍抗性增强的变异体。据我们所知,所有突变都是新突变,即尚未被随机诱变或DNA改组鉴定为有益,或在任何天然存在的TEMβ-内酰胺酶(革兰氏阴性β最普遍的类型)中均可见-内酰胺酶。这种组合方法可以快速改善可以通过实验筛选的任何特性,并为蛋白质工程提供了功能强大的广泛适用的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号